Monofer (Ferric Derisomaltose)

Ferric Derisomaltose, the active ingredient in Monofer, is an iron preparation presented as an intravenous solution for intravenous use. It is indicated for the treatment of iron deficiency anemia, particularly in patients who require rapid replenishment of iron stores such as those with chronic kidney disease or after major surgery.

GNH USA supplies Monofer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, providing reliable sourcing, regulatory support and cold‑chain logistics where required.

Monofer is used to treat conditions related to iron deficiency, helping restore normal hemoglobin and iron reserves.

- Iron deficiency anemia: restores hemoglobin levels and replenishes depleted iron stores. - Chronic kidney disease‑related anemia: provides intravenous iron when oral iron is ineffective. - Perioperative anemia: rapidly corrects iron deficit before surgical procedures.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Headache: transient headache during or after infusion. - Infusion site reactions: pain, erythema, or swelling at the injection site. - Dizziness: temporary light‑headedness. - Vomiting: occasional upset stomach.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Severe hypotension: sudden drop in blood pressure during infusion. - Acute respiratory distress: difficulty breathing or bronchospasm. - Iron overload: excessive iron accumulation in organs. - Cardiac arrest: rare but life‑threatening event.

Monofer should be administered with careful clinical assessment and monitoring.

- Allergy assessment: verify no known hypersensitivity to ferric derisomaltose or other IV iron products. - Cardiovascular monitoring: observe for hypotension during infusion. - Renal function: assess kidney function before administration. - Pregnancy and lactation: use only if potential benefit outweighs risk. - Drug interactions: avoid concurrent use with certain oral iron chelators. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Monofer may interact with other medicines; monitoring is advised.

Major Interactions (Avoid): - Oral iron chelators (e.g., deferoxamine): may reduce efficacy of ferric derisomaltose. - Concurrent IV iron products: increase risk of iron overload.

Moderate Interactions (Monitor Closely): - Erythropoiesis‑stimulating agents: may raise risk of hypertension. - Antihypertensive drugs: monitor blood pressure during infusion. - Phosphate binders: may affect serum phosphate levels.